The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

About Us

What treatment strategies are used in relapsed AML?

Curtis Lachowiez

January 5, 2021

During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, Know AML spoke to Curtis Lachowiez, MD Anderson Cancer Center, Houston, US, about treatment strategies used in relapsed acute myeloid leukemia. Lachowiez underlines the importance of using genetic information and the patient's condition to help guide treatment.